300 million life-years have been lost to cardiovascular diseases.1 It's time we reimagine patient care.
We are at an inflection point in the treatment of vascular disease. New technologies and opportunities for data-driven insights are being developed and adopted at unprecedented speed. How do we adopt these technologies to improve patient care?
Our new white paper examines a cross-section of the global healthcare system with over 1400 respondents including patients, physicians, and administrators to identify how to unlock innovation. Data is one key:
92% of patients think that sharing their personal health information is important for future generations.
88% of physicians prioritize having patient history information, but only 30% report the ability to easily access it.2
55% of administrators think technology can improve decision making at diagnosis.
It’s time to connect the care continuum for the 18 million people impacted by vascular disease today.3
In our primary research, we surveyed
Patients
- 70% with CAD or risk factors for CVD
- 30% with PAD
Cardiologists and other specialists that refer patients to ICs, VS, or IRs
Healthcare administrators or execs responsible for the selection, purchase and negotiation of cardiovascular devices/capital equipment
Across 9 countries: US, UK, China, Japan, India, France, Germany, Italy, and Brazil
Connecting the Care Continuum
Technology can connect the dots, empowering doctors to deliver better outcomes and creating a continuum of care that goes beyond intervention.
Patients want more individualized, personalized care:
72% of patients responded that health data that “lets my doctor see my problem and act on it in a tailored-for-me-manner” is very important.
61% want their doctors to use new technologies that monitor progress and provide information to show that the treatment is working.
72% of patients want more personalized, data-informed care
Physicians live in a data world – and need better ways to harness it:
55% of physicians feel they do not have enough time to spend with patients and 42% want more insight into aftercare and patient adherence.
88% of physicians prioritize having patient history information, but only 30% report the ability to easily access it.2 Similarly, 83% of physicians believe that access to medication adherence information is important, but only 17% can easily retrieve it electronically.
55% of physicians say limited time with patients is a major barrier
Administrators need to deliver more value – by looking ‘beyond intervention’
88% of administrators named patient satisfaction as highly important to the overall procedure experience in the hospital
46% of administrators say the lack of appropriate tools to aid with medication adherence and lifestyle change are a barrier to better care for patients; misdiagnoses or inability to property diagnose was an additional barrier identified by 41%
88% of administrators named patient satisfaction as highly important to the overall procedure experience in the hospital
Technology has the potential to help connect the dots across the care continuum - not just at the point of intervention.
A Vision for the Future: Improved Patient Care for Vascular Disease
Abbott leaders reflect on the challenges of treating vascular disease today and look beyond intervention
GBD 2017 Causes of Death Collaborators. Global, regional and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736-88
Please Enter the Pop Up text to be displayed in Pop Up here.
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
yes
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
[prod, crx3, samplecontent, publish, crx3tar]
test
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
